🇺🇸 Granisetron Injection in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 14

Most-reported reactions

1. Hypoaesthesia — 3 reports (21.43%)
2. Dyspnoea — 2 reports (14.29%)
3. Paraesthesia — 2 reports (14.29%)
4. Alanine Aminotransferase Increased — 1 report (7.14%)
5. Aspartate Aminotransferase Increased — 1 report (7.14%)
6. Blood Alkaline Phosphatase Increased — 1 report (7.14%)
7. Blood Pressure Increased — 1 report (7.14%)
8. Bone Marrow Failure — 1 report (7.14%)
9. Bone Marrow Transplant — 1 report (7.14%)
10. Coma — 1 report (7.14%)

Source database →

Frequently asked questions

Is Granisetron Injection approved in United States?

Granisetron Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Granisetron Injection in United States?

Eye & ENT Hospital of Fudan University is the originator. The local marketing authorisation holder may differ — check the official source linked above.